Clinical trials
Image clinical trials
Below are recruiting image clinical trials, each written for real people, not researchers. We’re tracking 2,186 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07423585RecruitingPhase 2
Tarlatamab for extensive stage small-cell lung cancer
This trial tests an experimental drug called tarlatamab for people newly diagnosed with extensive-stage small-cell lung cancer (SCLC). The goal is to see if tarlatamab can help shrink or control the cancer.
Columbus, OhioAges 18 years+ - NCT07037966Recruiting
Portable brain MRI for multiple sclerosis
This study tests a new portable brain MRI to see if it can help diagnose multiple sclerosis. It may be easier to use than regular machines.
ValenciaAges 18–65 - NCT07012044RecruitingPhase 1
Cedazuridine and decitabine after stem cell transplant for childhood leukemia
This trial tests if adding two chemotherapy drugs (cedazuridine and decitabine) along with a growth factor (filgrastim) can help prevent leukemia from coming back after a stem cell transplant. It is for children and young adults with high-risk acute myeloid leukemia who are in remission after transplant.
Birmingham, AlabamaAges Up to 21 years - NCT06709209Recruiting
AI tool for grading colitis during colonoscopy
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
LeuvenAges 18–75 - NCT06709339RecruitingPhase 4
Study of faricimab for Caucasian patients with polypoidal choroidal vasculopathy
This trial tests a drug called faricimab for a type of wet age-related macular degeneration called polypoidal choroidal vasculopathy (PCV). It aims to see if the drug is safe, works well, and how long the effects last in patients who have not been treated before.
MilanAges 50–90 - NCT06709846Recruiting
MRI brain scans in people with metabolic diseases
This study uses magnetic resonance imaging (MRI) to examine the brain in people with metabolic diseases compared to healthy volunteers. If you qualify, you will have an MRI scan to help researchers understand how metabolic conditions affect the brain.
UlmAges 18 years+ - NCT06712810RecruitingPhase 1
Q702 for blood cancers and histiocytic disorders
This study tests an experimental pill called Q702 for people with certain blood cancers and related disorders (like histiocytoses, myelofibrosis, and lymphomas) that have not responded to standard treatments. It aims to see if Q702 is safe and effective.
Scottsdale, ArizonaAges 18 years+ - NCT06715020Recruiting
Testing a new imaging method for breast cancer treatment
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
BeijingAges 18–75 - NCT06715839Recruiting
Digestive cancer imaging study with targeted antibodies
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06715826RecruitingPhase 1/Phase 2
Imaging breast cancer with a targeted radioactive tracer
This study is testing a new imaging method that uses a radioactive tracer to find breast cancer cells. It may help doctors see the cancer more clearly.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06717984Recruiting
AI model for breast cancer from tissue images
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
DhakaAges Any age - NCT06719414Recruiting
Using a special MRI to predict rectal cancer response to pre-surgery therapy
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
Guangzhou, GuangdongAges Any age - NCT06724289RecruitingEarly Phase 1
Psilocybin for prolonged grief
This trial tests if a single dose of psilocybin (a psychedelic drug) can help people with prolonged grief disorder. You'll receive counseling and be observed in a safe setting.
Charlottesville, VirginiaAges 18–65 - NCT06724627Recruiting
AI skin check app for walk-in clinic patients
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
The Bronx, New YorkAges Any age - NCT06728592Recruiting
Emergency stroke unit for ischemic stroke within 6 hours
This trial tests a dedicated emergency stroke unit for people with ischemic stroke who can get treatment within 6 hours of symptoms starting. It aims to see if this special care area improves outcomes.
Hong KongAges 18–100 - NCT06730464Recruiting
Predicting dangerous heart rhythms in non-ischemic heart disease
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
Milan, ItalyAges 18 years+ - NCT06730607Recruiting
Predicting heart rhythm problems after myocarditis
This study uses heart MRI scans to predict who might develop dangerous heart rhythms after recovering from myocarditis. It aims to find better ways to monitor patients and prevent emergencies.
Rozzano, MilanAges 18 years+ - NCT06731270RecruitingPhase 2
Diclofenac for advanced lung cancer on immunotherapy
This trial tests whether adding the anti-inflammatory drug diclofenac can help people with advanced non-small cell lung cancer whose tumors are growing while on a single immunotherapy drug. You must have been on immunotherapy for at least 12 weeks and have a growing tumor, but your doctor does not plan to change your treatment right away.
Atlanta, GeorgiaAges 18 years+ - NCT06732336RecruitingPhase 1/Phase 2
PET scan for HER2-low breast cancer
This trial uses a special PET scan to see if your breast cancer has low levels of a protein called HER2. This could help doctors choose the right treatment for you.
Sherbrooke, QuebecAges 18 years+ - NCT06733350RecruitingPhase 4
Testosterone therapy for low testosterone in men with low-risk prostate cancer
This study tests whether testosterone replacement therapy can safely improve low testosterone levels in men with low-risk prostate cancer who are not getting immediate treatment. It aims to help men feel better without worsening their cancer.
Buffalo, New YorkAges 18 years+ - NCT06735560Recruiting
PET scan with a tracer for liver, bile duct, or neuroendocrine tumors
This trial uses a special PET scan tracer (zirconium-labelled girentuximab) to see if it can find and track certain liver, bile duct, and pancreatic/intestinal neuroendocrine tumors. It may help doctors better understand your cancer and guide treatment decisions.
NantesAges 18 years+ - NCT06738615Recruiting
Symptoms and severity of a leaky mitral valve study
This study looks at how symptoms relate to the severity of mitral regurgitation, a leaky heart valve. Researchers want to better understand the link between what you feel and the actual degree of the leak.
Morristown, New JerseyAges 18 years+ - NCT06740942Recruiting
Studying nerve system changes after stroke with MRI and blood tests
This study looks at how the nervous system's automatic functions (like heart rate and blood pressure) change after a stroke. It uses MRI scans and blood tests to find patterns that might help doctors better understand and treat these changes.
Hamburg, Free and Hanseatic City of HamburgAges 18 years+ - NCT06742021Recruiting
MRI test to predict immune therapy response in lung cancer
This trial uses a special MRI technique (4D FreeBreathing) to see if it can predict how well immune therapy or targeted therapy works for your lung cancer. It may help doctors choose the best treatment for you more quickly.
Kunming, YunnanAges 18–75
Hear when a new Image trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for image?
- Yes. Clin2 currently lists 2,186 recruiting image studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a image trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a image trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.